Promotional Tone in Reviews of Menopausal Hormone Therapy After the Women's Health Initiative: An Analysis of Published Articles
McDonald, Christina Pike
Bell, Alicia M
Bethards, Emily Catherine
Scialli, Anthony R
PLoS medicine 2011 Mar; 8(3): e1000425
Even after the Women's Health Initiative (WHI) found that the risks of menopausal hormone therapy (hormone therapy) outweighed benefit for asymptomatic women, about half of gynecologists in the United States continued to believe that hormones benefited women's health. The pharmaceutical industry has supported publication of articles in medical journals for marketing purposes. It is unknown whether author relationships with industry affect promotional tone in articles on hormone therapy. The goal of this study was to determine whether promotional tone could be identified in narrative review articles regarding menopausal hormone therapy and whether articles identified as promotional were more likely to have been authored by those with conflicts of interest with manufacturers of menopausal hormone therapy.
Showing items related by title, author, creator and subject.
Schonberg, Mara A.; Davis, Roger B.; Wee, Christina C. (2005-07)
Fugh-Berman, Adriane; Epstein, Samuel; Fisher, Bernard; Redmond, Carol; Ford, Leslie G.; Nayfield, Susan G.; Greenwald, Peter (1992-11-26)
Fugh-Berman, Adriane; Epstein, Samuel; Fisher, Bernard; Redmond, Carol (1992-11-26)